Delta Financial Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$660K Buy
4,736
+626
+15% +$87.7K 0.17% 106
2025
Q4
$504K Buy
4,110
+2,025
+97% +$246K 0.13% 116
2025
Q3
$231K Buy
+2,085
New +$237K 0.07% 138

Other funds holding GILD

Delta Financial Advisors's GILD Position: Q1 2026 in Review

Delta Financial Advisors increased its Gilead Sciences (GILD) stake by 15% in Q1 2026, buying an estimated $87.7K and bringing the position to 4,736 shares worth $660K. The position accounts for 0.17% of the portfolio, ranked #106.

Delta Financial Advisors first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Delta Financial Advisors held 4,736 shares of Gilead Sciences worth $660K as of Q1 2026.
  • Delta Financial Advisors bought 626 Gilead Sciences shares in Q1 2026, an estimated $87.7K.
  • Gilead Sciences made up 0.17% of Delta Financial Advisors's portfolio in Q1 2026, its #106 holding.
  • Delta Financial Advisors first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Delta Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.